Chlorhexidine

Pharmacotherapeutic group:

antimicrobial drugs and antiseptics used in gynecology diabetes
Field of application:

gynecology
Dosage form:

Light-yellow vaginal suppositories light-yellow color.
Dosage:

16 mg
Quantity per pack:

10 12
Dispensing conditions:

Prescription only

Instructions for use

Trichomonal colpitis, cervical erosion, vulvar itching, prevention of sexually transmitted diseases (including gonorrhea, syphilis, trichomoniasis, chlamydia, and ureaplasmosis); prevention of infectious and inflammatory complications in obstetrics and gynecology (before surgical treatment of gynecological diseases, before childbirth, abortion, before and after IUD insertion, before and after cervical diathermocoagulation, before intrauterine examinations); treatment of bacterial vaginosis and colpitis (including nonspecific, mixed, and trichomoniasis-related forms).

Method of administration and dosage

Directions for use: Remove the suppository from its blister pack and insert it into the vagina while lying on your back. For the treatment of bacterial vaginosis and colpitis (including nonspecific, mixed, and trichomonal forms), administer 1 suppository twice daily for 7–10 days. If necessary, the course can be extended to 20 days. To prevent sexually transmitted infections (chlamydia, ureaplasma, trichomoniasis, gonorrhea, syphilis, genital herpes, and others), insert 1 suppository no later than 2 hours after sexual intercourse.

Special instructions and precautions for use

If vaginal bleeding occurs during intravaginal use, discontinue the use of chlorhexidine. Chlorhexidine must not come into contact with the eyes (except for special dosage forms intended for ophthalmic use), nor should it come into contact with the meninges or the auditory nerve.

Contraindications

Hypersensitivity to chlorhexidine.

Shelf life

2 years

Updated packaging design from Pharmproject JSC

In 2023, Pharmproject JSC developed a unified packaging design for its pharmaceutical products.

The new, eye-catching packaging makes it easy to spot the product on the shelf, even for people with impaired vision. Large font, colours, and images on the packaging make it easy to distinguish one medicinal product from another and clearly identify the dosage, thereby reducing the likelihood that a medicinal product is taken incorrectly or that a pharmacy dispenses the wrong medicinal product or strength. Medicinal products registered by Pharmproject prior to 2023 are now available in new packaging.

Before

After

In 2023, Pharmproject JSC developed a unified packaging design for its pharmaceutical products.

Drug
Safety

In accordance with Russian law, international standards, and the company’s quality policy, Pharmproject monitors the safety and quality of the medicinal products it manufactures throughout their entire lifecycle.

If you experience an adverse reaction while taking any of Pharmproject’s products, be sure to report it to a pharmacovigilance specialist

Fill out the form